The Effects of Trimetazidine on P-Wave Duration and Dispersion in Heart Failure Patients


GUNES Y., Tuncer M. , GUNTEKIN U., Akdag S. , GÜMRÜKÇÜOĞLU H. A.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.32, ss.239-244, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1111/j.1540-8159.2008.02208.x
  • Dergi Adı: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
  • Sayfa Sayıları: ss.239-244

Özet

Background: P-wave duration and dispersion (PWD) have been shown to be noninvasive predictors for development of atrial fibrillation. Thus, it may be possible to attenuate atrial fibrillation risk through normalization of P-wave duration and dispersion. Trimetazidine, a metabolic modulator, has been reported to improve cardiac function in heart failure (HF) patients.